WO2024033794 - RNA ENCODING VIRUS-LIKE PARTICLES AND USES THEREOF
National phase entry is expected:
Publication Number
WO/2024/033794
Publication Date
15.02.2024
International Application No.
PCT/IB2023/057979
International Filing Date
08.08.2023
Title **
[English]
RNA ENCODING VIRUS-LIKE PARTICLES AND USES THEREOF
[French]
ARN CODANT POUR DES PARTICULES DE TYPE VIRUS ET SES UTILISATIONS
Applicants **
SEQIRUS INC.
Inventors
BEDI, Sukhmani
CHANG, Cheng
ALLEN, Pirada
Priority Data
63/370,725
08.08.2022
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
USPTO
* |
| * | |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| 译文 |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 4444 | |
| EPO | Filing, Examination, Granting | 53884 | |
| Japan | Filing, Examination, Granting | 3835 | |
| South Korea | Filing, Examination, Granting | 5768 | |
| USA | Filing, Examination, Granting | 13960 |
Total:
81,891
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present disclosure relates to a composition comprising one or more ribonucleic acids (RNAs) encoding virus-like particle (VLP) forming elements of an influenza virus. The present disclosure further provides uses of the composition.[French]
La présente invention concerne une composition comprenant un ou plusieurs acides ribonucléiques (ARN) codant pour des éléments formant des particules de type virus (VLP) d'un virus de la grippe. La présente invention concerne en outre des utilisations de la composition.